The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 2, 2026

Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)

Fried, Robert
Robert Fried serves as the Chief Executive Officer of Niagen Bioscience Inc. Mr. Fried brings over 10 years of experience in the bioscience and longevity sector, having joined the company’s board of directors in 2015 before being appointed President and Chief Operating Officer in 2017, and Chief Executive Officer in April 2018. In 2016, Mr. Fried founded Healthspan Research LLC, which developed the Tru Niagen consumer brand before being acquired by ChromaDex in March 2017. His commitment to advancing longevity science was established through early strategic investments in biotechnology companies focused on cellular health, stem cell research, and regenerative medicine. Prior to his leadership in the bioscience sector, Mr. Fried demonstrated entrepreneurial success in digital media as the founder and CEO of Feeln (acquired by Hallmark Cards) and WHN, an e-commerce technology provider. His earlier career includes executive roles at Savoy Pictures (CEO) and Columbia Pictures (Executive Vice President). Mr. Fried’s achievements in media production have been recognized with both Academy and Emmy Awards. Mr. Fried holds a Bachelor of Science degree from Cornell University and a Master of Business Administration from Columbia University Graduate School of Business. Profile
Word count: 3,428

TWST: Let’s start with a brief overview of the company — how it started and some milestones.

Mr. Fried: The company was started back in

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)
Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
$TDW, Tidewater’s Supply Moat Widens as High Construction Costs Make New Vessels Financially Unviable for Competitors
Booking Holdings $BKNG: Scale Moat and Strategic OpenAI Pivot Neutralize AI Disruption Fears
Supply Constraints Translate Into Pricing Power for Eagle Materials
ANALYST INTERVIEWS
Argenx Builds Momentum on Strong Execution and Expanding Indications
Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
Uptick in M&A Among Tailwinds Boosting Biotech Sector
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy